Three allosteric modulators act at a common site, distinct from that of competitive antagonists, at muscarinic acetylcholine M2 receptors

Journal of Pharmacology and Experimental Therapeutics

Volumn 282, Issue 1, 1997, Pages 278-285

  Lanzafame, Alfred ^a   Christopoulos, Arthur ^a   Mitchelson, Fred ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALCURONIUM; ATROPINE; CARBACHOL; GALLAMINE; HEPTANE 1,7 BIS(DIMETHYL 3' PHTHALIMIDOPROPYL)AMMONIUM BROMIDE; METHYLSCOPOLAMINE; MUSCARINIC M2 RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG;

ALLOSTERISM; ANIMAL TISSUE; ARTICLE; BINDING COMPETITION; BINDING SITE; CONTROLLED STUDY; DRUG EFFECT; DRUG RECEPTOR BINDING; FEMALE; GUINEA PIG; HEART ATRIUM MUSCLE; INOTROPISM; MALE; NONHUMAN; PRIORITY JOURNAL;

ALCURONIUM; ALLOSTERIC REGULATION; ANIMALS; ATROPINE; FEMALE; GALLAMINE TRIETHIODIDE; GUINEA PIGS; MALE; MUSCARINIC ANTAGONISTS; N-METHYLSCOPOLAMINE; RECEPTOR, MUSCARINIC M2; RECEPTORS, MUSCARINIC; SCOPOLAMINE DERIVATIVES;

EID: 0030824653     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. BLACK, J. W., GERSKOWITCH, V. P., LEFF, P. AND SHANKLEY, N. P.: Analysis of competitive antagonism when this property occurs as part of a pharmacological resultant. Br. J. Pharmacol. 89: 547-555, 1986.
2. CHRISTOPOULOS, A., LOIACONO, R. AND MITCHKLSON, F.: Binding of the muscarine receptor antagonist heptane-1,7-bis(dimethyl-3′-pthalimidopropyl) ammonium bromide at cholinoceptor sites. Eur. J. Pharmacol 246: 1-8, 1993.
3. CHRISTOPOULOS, A. AND MITCHELSON, F.: Assessment of the allosteric interactions of the bisquaternary heptane-1,7-bis(dimethyl-3′-pthalimidopropyl) ammonium bromide at M1 and M2 muscarine receptors. Mol. Pharmacol. 46: 105-114, 1994.
4. CLARK, A. L. AND MITCHELSON, F.: The inhibitory effect of gallamine on muscarinic receptors. Br. J. Pharmacol. 58: 323-331, 1976.
5. COOK, N. S. AND HAYLETT, D. G.: Effects of apamin, quinine and neuromuscular blocking blockers on calcium-activated potassium channels in guinea-pig hepatocytes. J. Physiol. 358: 373-394, 1985.
6. + channels by gallamine and a novel bis-quaternary quinolinium cyclophane, UCL 1530. Br. J. Pharmacol. 117: 35-42, 1996.
7. EHLERT, F. J.: Estimation of the affinities of allosteric ligands using radioligand binding and pharmacological null methods. Mol. Pharmacol. 33: 187-194, 1988a.
8. EHLERT, F. J.: Gallamine allosterically antagonizes muscarinic receptor-mediated inhibition of adenylate cyclase activity in the rat myocardium. J. Pharmacol. Exp. Ther. 247: 596-602, 1988b.
9. ELLIS, J. AND SEIDENBERG, M.: Gallamine exerts biphasic allosteric effects at muscarinic receptors. Mol. Pharmacol. 35: 173-176, 1989.
10. ELLIS, J. AND SEIDENBERG, M.: Two allosteric modulators interact at a common site on cardiac muscarinic receptors. Mol. Pharmacol. 42: 638-641, 1992.
11. 6 muscarinic acetylcholine receptors. J. Pharmacol. Exp. Ther. 274: 1077-1083, 1995.
12. JAKUBÍK, J., BACÁKOVÁ, L., LISÁ, V., EL-FAKAHANY, E. E. AND TUCEK, S.: Activation of muscarinic acetylcholine receptors via their allosteric binding sites. Proc. Nat. Acad. Sci. USA 93: 8705-8709, 1996.
13. KENAKIN, T. AND BOSELLI, C.: Pharmacologic discrimination between receptor heterogeneity and allosteric interaction: Resultant analysis of gallamine and pirenzepine antagonism of muscarinic responses in rat trachea. J. Pharmacol. Exp. Ther. 250: 944-952, 1989.
14. 2 receptors. Eur. J. Pharmacol. 316: 27-32, 1996.
15. LEE, N. H., HU, J. AND EL-FAKAHANY, E. E.: Modulation by certain conserved aspartate residues of the allosteric interaction of gallamine at the m1 muscarinic receptor. J. Pharmacol. Exp. Ther. 262: 312-316, 1992.
16. LÜLLMANN, H., OHNESORGE F. K., SCHAUWECKER G. C. AND WASSERMANN O.: Inhibition of the actions of carbachol and DFP on guinea pig isolated left atria by alkane bis-ammonium compounds. Eur. J. Pharmacol. 6, 241-247, 1969.
17. MAAß, A., KOSTENIS, E. AND MOHR, K.: Potentiation by alcuronium of the antimuscarinic effect of N-methylscopolamine in guinea pig left atria. Eur. J. Pharmacol. 272: 103-106, 1995.
18. MITCHELSON, F.: Antimuscarinic action of an alkane-bis-ammonium compound alone and in combination with (+)-benzetimide. Eur. J. Pharmacol. 33: 237-246, 1975.
19. PATON, W. D. M. AND RANG, H. P.: The uptake of atropine and related drugs by intestinal smooth muscle of the guinea-pig in relation to acetylcholine receptors. Proc. R. Soc. Lond. B. Biol. Sci. 163: 1-44, 1965.
20. PROŠKA, J. AND TUCEK, S.: Mechanisms of steric and cooperative actions of alcuronium on cardiac muscarinic acetylcholine receptors. Mol. Pharmacol. 45: 709-717, 1994.
21. PROŠKA, J. AND TUCEK, S.: Competition between positive and negative allosteric effectors on muscarinic receptors. Mol. Pharmacol. 48: 696-702, 1995.
22. STOCKTON, J. M., BIRDSALL, N. J. M., BURGEN, A. S. V. AND HULME, E. C.: Modification of the binding properties of muscarinic receptors by gallamine. Mol. Pharmacol. 23: 551-557, 1983.
23. TRANKLE, C., KOSTENIS, E., BURGMER, U. AND MOHR, K.: Search for lead structures to develop new allosteric modulators of muscarinic receptors. J. Pharmacol. Exp. Ther. 279: 926-933, 1996.
24. TUCEK, S., MUSÍLKOVÁ, J., NEDOMA, J., PROŠKA, J., SHELKOVNIKOV, S. AND VORLÍCEK, J.: Positive cooperativity in the binding of alcuronium and N-methylscopolamine to muscarinic acetylcholine receptors. Mol. Pharmacol. 38: 674-680, 1990.
25. TUCEK, S. AND PROŠKA, J.: Allosteric modulation of muscarinic acetylcholine receptors. Trends Pharmacol. Sci. 16: 205-212, 1995.
26. WAELBROECK, M.: Identification of drugs competing with d-tubocurarine for an allosteric site on cardiac muscarinic receptors. Mol. Pharmacol. 46: 685-69, 1994.